Graded Renal Response Criteria for Light Chain (AL) Amyloidosis
Eli Muchtar(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), Heather Landau(Memorial Sloan Kettering Cancer Center), Kaya Veelken(Heidelberg University), Darren Foard(University College London), Vaishali Sanchorawala(Boston Medical Center), Ronald Witteles(Alnylam Pharmaceuticals (United States)), Nelson Leung(WinnMed), Efstathios Kastritis(National and Kapodistrian University of Athens), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Shaji Kumar(Mayo Clinic), Suzanne Lentzsch(Columbia University Irving Medical Center), Joan Bladé(Hospital Clínic de Barcelona), Meletios Α. Dimopoulos(Korea University), Oliver Cohen(University Hospitals Birmingham NHS Foundation Trust), Brendan Wisniowski(The Royal Free Hospital), Stefan Schönland(Heidelberg University), Raphaël Szalat(Boston University), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Ashutosh Wechalekar(University College Hospital), Ute Hegenbart(Heidelberg University), Alexander Coltoff(Columbia University Irving Medical Center), Giovanni Palladini(University of Pavia), Paolo Milani(University of Pavia), Michaela Liedtke(Cancer Institute (WIA)), Giampaolo Merlini(University of Pavia), Angela Dispenzieri(Mayo Clinic), M. Teresa Cibeira(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Erica Petrlik(Memorial Sloan Kettering Cancer Center)
Cited by 10
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k